News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID)

Study Status:

Open For Enrollment

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The primary outcome measures in the phase II evaluation will be duration of symptoms, SARS-CoV-2 RNA below lower limit of quantification by nasopharyngeal (NP) swabs, and safety. The primary outcome measures in the phase III evaluation will be the composite of hospitalization due to any cause or death due to any cause, and safety.

Information: 

Principal Investigator
Marissa Gomez-Martinez, MD
Sponsor
NIH/NIAID
Type of Trial
Interventional
© 2022 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram